InvestLog
PRLD logo

PRLD

Prelude Therapeutics IncorporatedNASDAQHealthcare
$3.46+0.29%ClosedMarket Cap: $192.8M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-11Citizens—Market Outperform—
2025-09-23HC Wainwright & Co.—Buy—
2025-08-18JMP Securities—Market Outperform—
2025-05-05HC Wainwright & Co.—Buy—
2025-04-29JMP Securities—Market Outperform—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.32$100.0M1
Sun Dec 31$0.09$200.0M1
Mon Dec 31$-0.03$100.0M1
Tue Dec 31$0.37$100.0M1